InflaRx (IFRX) Earnings Date & Reports

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IFRX is expected to report earnings to fall 8.38% to -7 cents per share on August 06

Q2'26

Est.

$-0.07

Q1'26

Beat

by $0.06

Q4'25

Est.

$-0.15

Q3'25

Missed

by $0.03

Q2'25

Missed

by $0.04

The last earnings report on May 07 showed earnings per share of -7 cents, beating the estimate of -14 cents. With 1.49M shares outstanding, the current market capitalization sits at 266.60M.

View a ticker or compare two or three

Compare

IFRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for IFRX